The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase IV study of ApricityCARE program for cancer adverse events rapid evaluation to improve treatment outcomes of ethnic/racial minority patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors (ICI).
 
Brian S. Henick
Honoraria - DAVA Oncology; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; IDEAYA Biosciences; Jazz Pharmaceuticals; Regeneron; Sorrento Therapeutics
Research Funding - Genentech/Roche (Inst); Johnson & Johnson/Janssen (Inst); NexImmune (Inst); Stand Up 2 Cancer (Inst); V Foundation (Inst)
 
Rajwanth Veluswamy
Consulting or Advisory Role - AstraZeneca; BeiGene; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Merus; Novocure; Regeneron
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb (Inst); Onconova Therapeutics (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Balazs Halmos
Consulting or Advisory Role - Apollomics; Arcus Biosciences; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Genentech/Roche; Janssen Oncology; Lilly; Merck; merus; Novartis; Pfizer; Takeda; Turning Point Therapeutics; Veracyte
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen; AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Elevation Oncology (Inst); Forward (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Takeda (Inst); Tesaro/GSK (Inst)
 
Kristen Labbe
No Relationships to Disclose
 
Naomi Sender
No Relationships to Disclose
 
Sarah Sta Ana
No Relationships to Disclose
 
Lanyi Nora Chen
No Relationships to Disclose
 
Salman Rafi Punekar
Research Funding - Astellas Pharma (Inst); Constellation Pharmaceuticals (Inst); NCI (Inst); Prelude Therapeutics (Inst); Revolution Medicines (Inst); Simcere (Inst); Tango Therapeutics (Inst); VITRAC Therapeutics (Inst)
 
Jasleena Singh
No Relationships to Disclose
 
Matthew Lee
No Relationships to Disclose
 
Catherine A. Shu
Consulting or Advisory Role - Arcus Biosciences; AstraZeneca; Genentech/Roche; Gilead Sciences; Janssen; Takeda
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Janssen (Inst)
 
Benjamin Herzberg
Honoraria - Boxer Capital; Eisai; OncLive/MJH Life Sciences
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca; IDEAYA Biosciences (Inst); Monte Rosa Therapeutics (Inst); Prelude Therapeutics (Inst); Repare Therapeutics (Inst); Revolution Medicines (Inst); Seagen (Inst)
 
Lynda Chin
Employment - Apricity Health
Leadership - Apricity Health
Stock and Other Ownership Interests - Apricity Health
 
Vamsidhar Velcheti
Honoraria - Galvanize Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Novocure; Picture Health; Regeneron; Taiho Oncology; Takeda
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); RSIP Vision (Inst); Trovagene (Inst)